Demystifying Deprescribing: Less is More
Note: Institutional group rates are available upon request.
Select type to purchase:
Funding Disclosure: No commercial funding has been accepted for the activity.
Ebtesam Ahmed, PharmD, MS
Director of Pharmacy Internship
MJHS Institute for Innovation in Palliative Care
Associate Clinical Professor, St. John’s University
Purpose: Deprescribing can be defined as the process of dose reduction, withdrawal, or discontinuation of medications which are considered inappropriate in an individual. The goal of this webinar is to provide an overview of “deprescribing.” Potential benefits and harms will be discussed, followed by the barriers, challenges to and enablers of deprescribing. The webinar will also provide practical recommendations to recognize opportunities and strategies for deprescribing in clinical practice.
- Discuss principles of safe medication discontinuation (renal dosing, drug interactions)
- Review guidelines for deprescribing across continuum of care
- Provide deprescribing resources for providers and patients
Target Audience: palliative care specialists, pain specialists, primary care providers, nurse practitioners, registered nurses, advance practice nurses, registered nurses with a specialty in palliative care/hospice, pharmacists, allied health professionals, fellows, residents, and medical students
Criteria for Successful Completion:
- Attendance at entire session
- Submission of completed evaluation form
- Successful completion of a posttest (70% passing grade for physicians, non-physicians, and nurses)
Continuing Education Credits: 1.0
Release Date: August 7, 2018
Expiration Date: June 15, 2021 (for physicians and non-physicians); February 14, 2021 (for nurses)
Continuing Education Accreditation
Physicians: This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Medical Society of the State of New York (MSSNY) through the joint providership of MSSNY and the MJHS Institute for Innovation in Palliative Care. MSSNY is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: MJHS Institute for Innovation in Palliative Care is an approved provider of continuing nursing education by The Alabama State Nurses Association, an accredited provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Individual: $25 (includes CME/CE certificate)
Ebtesam Ahmed, PharmD, MS, has no financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in these materials. Any discussion of investigational or unlabeled uses of a product will be identified.
Russell K. Portenoy, MD, Faculty and Planner, has indicated a relationship with Tabula Rasa for research support.
No other Planning Committee Member has any disclosures.
Planning Committee Members
Lara Dhingra, PhD
Colleen Fleming-Damon, PhD, ANP-BC, ACHPN, FT
Myra Glajchen, DSW
Helena Knotkova, PhD
Russell K. Portenoy, MD
Karen Richards, PhD, EdS
Wini Schein, BA